Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Animal Feed

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1883925

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1883925

Eubiotics

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Eubiotics Market to Reach US$11.2 Billion by 2030

The global market for Eubiotics estimated at US$7.3 Billion in the year 2024, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Probiotics, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Organic Acids segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 6.8% CAGR

The Eubiotics market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Eubiotics Market - Unveiling Key Trends & Growth Catalysts

Why Are Eubiotics Transforming Animal Nutrition and Gut Health?

Eubiotics have emerged as a critical component in modern animal nutrition, playing a pivotal role in improving gut health, enhancing immune response, and optimizing feed efficiency. These biologically active compounds include probiotics, prebiotics, organic acids, and essential oils, all of which contribute to maintaining a balanced microbiota in livestock and poultry. With growing concerns about antibiotic resistance and the push for antibiotic-free animal feed solutions, eubiotics are becoming an essential alternative for maintaining animal health and productivity.

The demand for eubiotics has risen significantly as livestock farmers and feed manufacturers seek natural, sustainable solutions to enhance growth performance while ensuring food safety. Probiotics and prebiotics work synergistically to promote beneficial gut bacteria, reducing digestive disorders and improving nutrient absorption. Organic acids, such as fumaric and formic acid, help lower pH levels in the gut, inhibiting the growth of pathogenic bacteria. Meanwhile, essential oils derived from plants like oregano and thyme offer antimicrobial and anti-inflammatory benefits. As consumer awareness of food quality and sustainability grows, the adoption of eubiotics is expanding rapidly across poultry, swine, cattle, and aquaculture industries.

How Are Innovations and Sustainability Trends Reshaping the Eubiotics Market?

Technological advancements and sustainability trends are driving the evolution of the eubiotics market, leading to the development of more efficient and targeted gut health solutions. One of the most significant innovations is the introduction of microencapsulated eubiotics, which protect active ingredients from degradation and ensure controlled release in the digestive tract. This technology enhances the efficacy of probiotics, prebiotics, and essential oils, allowing for more consistent health benefits and improved feed conversion ratios in livestock.

Another major shift in the industry is the increasing focus on precision nutrition and personalized eubiotic formulations. Researchers are leveraging genomics and microbiome analysis to develop customized eubiotic solutions tailored to specific livestock species, life stages, and environmental conditions. Additionally, the rising demand for organic and antibiotic-free meat products has encouraged the adoption of plant-based eubiotics, which offer natural antimicrobial properties without compromising animal growth rates. Regulatory frameworks are also playing a crucial role in shaping the market, with governments worldwide imposing stricter limits on antibiotic growth promoters (AGPs) and encouraging the use of natural alternatives like eubiotics. These trends are not only improving livestock health and productivity but also promoting sustainability and reducing the environmental impact of animal farming.

Which Livestock Sectors Are Driving the Expanding Eubiotics Market?

The poultry industry is one of the largest consumers of eubiotics, as maintaining optimal gut health is crucial for improving feed efficiency, egg production, and meat quality. Probiotics and organic acids are widely used in broiler and layer diets to prevent intestinal diseases such as necrotic enteritis and coccidiosis. With the rising demand for antibiotic-free chicken and organic poultry products, eubiotics are becoming an indispensable component in poultry feed formulations.

The swine sector is another key driver of eubiotic adoption, particularly in piglet diets where gut health plays a critical role in early growth and disease resistance. Prebiotics and essential oils are commonly added to swine feed to reduce post-weaning diarrhea, enhance immunity, and improve overall weight gain. Meanwhile, the ruminant industry, including cattle and dairy farming, is increasingly incorporating eubiotics to optimize rumen fermentation, improve milk yield, and reduce methane emissions. In aquaculture, probiotics and organic acids are being used to enhance fish and shrimp gut health, ensuring higher survival rates and better feed utilization. As global meat consumption rises and sustainability concerns grow, eubiotics are expected to play a greater role in shaping the future of livestock nutrition.

What’s Fueling the Rapid Growth of the Eubiotics Market?

The growth in the global eubiotics market is driven by several factors, including the rising demand for antibiotic-free animal feed, increasing consumer awareness of food safety, and the push for sustainable livestock production. Stricter regulations banning the use of antibiotic growth promoters (AGPs) in animal feed, particularly in Europe and North America, have accelerated the shift toward natural gut health solutions such as probiotics, prebiotics, and organic acids. Additionally, the growing demand for high-quality animal protein, including poultry, pork, beef, and seafood, has fueled the need for feed additives that enhance productivity while minimizing disease outbreaks.

Advancements in microbiome research and feed formulation technologies have further expanded the application of eubiotics, enabling livestock producers to achieve better feed efficiency and lower production costs. The expansion of precision farming techniques, where real-time data on animal health and nutrition is used to optimize feed additives, is also driving the adoption of targeted eubiotic solutions. Furthermore, increasing investment in sustainable agriculture and climate-friendly livestock practices is promoting the use of eubiotics as a tool for reducing antibiotic dependency and improving overall animal welfare. With continued innovation, regulatory support, and rising consumer demand for natural and safe meat products, the eubiotics market is poised for significant growth, solidifying its role as a cornerstone of modern animal nutrition.

SCOPE OF STUDY:

The report analyzes the Eubiotics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Probiotics, Organic Acids, Phytogenics, Prebiotics, Enzymes); Form (Solid, Liquid); Function (Nutrition & Gut Health, Immunity, Yield, Other Functions); End-Use (Poultry, Swine, Ruminants, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 21 Featured) -

  • Bioproton Pty., Ltd.
  • Calpis Co., Ltd.
  • Cargill, Inc.
  • Dostofarm GmbH
  • DSM-Firmenich AG
  • Koninklijke DSM N.V.
  • MSPrebiotics, Inc.
  • NATURE'S TRUTH UK
  • Nuproxa Switzerland Ltd

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP11869

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Eubiotics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Natural Feed Additives Boosting Eubiotics Market
    • Increasing Awareness of Animal Health and Nutrition Enhancing Eubiotics Use
    • Impact of Antibiotic Bans in Feed on Rising Eubiotics Adoption
    • Technological Advances in Microencapsulation Improving Eubiotics Efficacy
    • Market Trends Toward Organic and Non-GMO Feed Ingredients
    • Expansion of Probiotics and Prebiotics in Animal Diets Driving Market Growth
    • Consumer Preferences Shifting Toward Sustainable Livestock Production
    • Future Directions: Development of Species-specific Eubiotics
    • Market Response to Global Increase in Meat Consumption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Eubiotics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Eubiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Organic Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Organic Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Phytogenics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Phytogenics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Phytogenics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Solid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Solid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Solid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Nutrition & Gut Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Nutrition & Gut Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Immunity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Immunity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Yield by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Yield by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Poultry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Swine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Ruminants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Ruminants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Eubiotics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Eubiotics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 149: UK Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 152: UK Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Eubiotics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 185: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of World Historic Review for Eubiotics by Type - Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of World 15-Year Perspective for Eubiotics by Type - Percentage Breakdown of Value Sales for Probiotics, Organic Acids, Phytogenics, Prebiotics and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Form - Solid and Liquid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of World Historic Review for Eubiotics by Form - Solid and Liquid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of World 15-Year Perspective for Eubiotics by Form - Percentage Breakdown of Value Sales for Solid and Liquid for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of World Recent Past, Current & Future Analysis for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of World Historic Review for Eubiotics by Function - Nutrition & Gut Health, Immunity, Yield and Other Functions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of World 15-Year Perspective for Eubiotics by Function - Percentage Breakdown of Value Sales for Nutrition & Gut Health, Immunity, Yield and Other Functions for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of World Recent Past, Current & Future Analysis for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of World Historic Review for Eubiotics by End-Use - Poultry, Swine, Ruminants and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of World 15-Year Perspective for Eubiotics by End-Use - Percentage Breakdown of Value Sales for Poultry, Swine, Ruminants and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!